Sanofi (NASDAQ:SNY – Free Report) – Equities researchers at Leerink Partnrs decreased their Q2 2024 earnings estimates for Sanofi in a report released on Tuesday, May 28th. Leerink Partnrs analyst D. Risinger now expects that the company will post earnings per share of $0.89 for the quarter, down from their previous forecast of $0.90. The […]
Sanofi (OTCMKTS:SNYNF – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 347,800 shares, a growth of 16.9% from the April 30th total of 297,400 shares. Based on an average daily volume of 1,900 shares, the short-interest […]
Catalytic Wealth RIA LLC acquired a new position in Sanofi (NASDAQ:SNY – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,965 shares of the company’s stock, valued at approximately $346,000. Other large investors have also added […]
Primecap Management Co. CA decreased its position in Sanofi (NASDAQ:SNY – Free Report) by 0.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,123,030 shares of the company’s stock after selling 3,960 shares during the period. Primecap Management Co. CA’s holdings in Sanofi were worth $55,848,000 as of its most recent filing […]
Shares of Sanofi (NASDAQ:SNY – Get Free Report) have earned an average rating of “Hold” from the five ratings firms that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price objective […]